I bring three decades of professional experience, including over 20 years operating inside demanding biotech and pharmaceutical environments — where scientific ambition, capital constraints and governance expectations intersect.

My career has evolved from building project and portfolio capabilities from the ground up to leading Programs & Portfolio governance at executive level.

I have operated at the Executive–Board interface in environments where execution credibility directly influenced valuation.

Today, I work as a Fractional Chief of Staff and Portfolio & Governance Executive for biotech leadership teams navigating structural inflection points.

Executive perspective shaped by complexity.

Carole ABEL
Founder - enAbel Consulting

How I operate

I do not introduce parallel structures.
I do not add unnecessary layers.

I intervene to:

  • Clarify strategic intent

  • Align leadership execution

  • Reinforce accountability

  • Protect decision quality under pressure

Clarity. Alignment. Accountability.

Leadership Philosophy

Complexity does not require more activity.
It requires better structure.

Execution discipline is not about control —
it is about creating shared visibility, mutual responsibility and credible delivery.

My approach is grounded in:

  • Intentional clarity

  • Respectful alignment

  • Reciprocal leadership

  • Accountable follow-through

Executive Experience & Selected Leadership Mandates

Built on three decades of professional experience, including over 20 years in global biotech environments where portfolio governance, capital discipline and execution credibility directly influenced valuation.

Holds an Executive MBA from EDHEC Business School and a Master’s in Project Management, grounded in a scientific foundation in biology and chemistry.

Synendos Therapeutics

Strategic portfolio structuring and executive decision support during critical development and financing phases.

MindMed (now Definium Therapeutics)

Vice President, Programs & Portfolio Office

Operated as an executive integrator across Programs, Finance and Executive leadership, reinforcing portfolio focus, milestone discipline and Board-grade governance under capital pressure.

Creso Pharma

Governance and financial structuring advisory in growth and transformation context.